Drugs / HSK39004
last change 3 days ago re-read 3 minutes ago

HSK39004

Developed for
chronic obstructive pulmonary disease
Investigated by
Haisco Pharmaceutical Group Co., Ltd.

Trials 9

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 12 trials
Phase 1 NCT06971198 Feb → Mar 2025 — Haisco Pharmaceutical Group Co., Ltd. Completed No outcome recorded
Phase 1 NCT06905847 Sep 2024 → Jan 2025 — Haisco Pharmaceutical Group Co., Ltd. Completed No outcome recorded
Phase 24 trials
Phase 2 NCT07425210 Mar 2026 → Jul 2027 expected chronic obstructive pulmonary disease Haisco Pharmaceutical Group Co., Ltd. Not yet recruiting No outcome recorded
Phase 2 NCT07108699 Aug 2025 → Aug 2026 overdue chronic obstructive pulmonary disease Haisco Pharmaceutical Group Co., Ltd. Active not recruiting No outcome recorded
Phase 2 NCT07331402 Jul → Dec 2025 overdue chronic obstructive pulmonary disease Haisco Pharmaceutical Group Co., Ltd. Active not recruiting No outcome recorded
Phase 2 NCT07140328 Apr → Jul 2025 overdue chronic obstructive pulmonary disease Haisco Pharmaceutical Group Co., Ltd. Recruiting No outcome recorded
Phase 33 trials
Phase 3 NCT07658339 Jul 2026 → Jun 2027 expected chronic obstructive pulmonary disease Haisco Pharmaceutical Group Co., Ltd. Not yet recruiting No outcome recorded
Phase 3 NCT07634367 Jul 2026 → Dec 2027 expected chronic obstructive pulmonary disease Haisco Pharmaceutical Group Co., Ltd. Not yet recruiting No outcome recorded
Phase 3 NCT07583849 May 2026 → Sep 2027 expected chronic obstructive pulmonary disease Haisco Pharmaceutical Group Co., Ltd. Recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 9 sources stand behind the page.

FieldValueCited text
Known as HSK39004 ClinicalTrials.gov intervention name — accepted as the source's own label NCT06971198 ↗
8

NCT07331402 ↗

NCT07658339 ↗

NCT07583849 ↗

NCT07425210 ↗

NCT07634367 ↗

NCT06905847 ↗

NCT07140328 ↗

NCT07108699 ↗

Route Inhaled “Single or multiple inhaled HSK39004” NCT06905847 ↗